Resminostat hydrochloride
≥98%
- Product Code: 102283
CAS:
1187075-34-8
| Molecular Weight: | 385.87 g./mol | Molecular Formula: | C₁₆H₂₀ClN₃O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Resminostat hydrochloride is primarily used in the field of oncology as a histone deacetylase (HDAC) inhibitor. It is being investigated for its potential to treat various types of cancers, including hepatocellular carcinoma (HCC) and cutaneous T-cell lymphoma (CTCL). By inhibiting HDAC enzymes, it helps in the regulation of gene expression, leading to the suppression of tumor growth and the induction of cancer cell death. Additionally, it is being explored for its role in combination therapies, where it may enhance the efficacy of other anticancer drugs. Its application in clinical trials aims to provide new therapeutic options for patients with resistant or advanced cancers.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98 |
| Lcms | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿15,800.00 |
+
-
|
| 0.010 | 10-20 days | ฿29,600.00 |
+
-
|
Resminostat hydrochloride
Resminostat hydrochloride is primarily used in the field of oncology as a histone deacetylase (HDAC) inhibitor. It is being investigated for its potential to treat various types of cancers, including hepatocellular carcinoma (HCC) and cutaneous T-cell lymphoma (CTCL). By inhibiting HDAC enzymes, it helps in the regulation of gene expression, leading to the suppression of tumor growth and the induction of cancer cell death. Additionally, it is being explored for its role in combination therapies, where it may enhance the efficacy of other anticancer drugs. Its application in clinical trials aims to provide new therapeutic options for patients with resistant or advanced cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :